rs78575519

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_025074.7(FRAS1):​c.4635G>A​(p.Pro1545Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 1,612,866 control chromosomes in the GnomAD database, including 40,863 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2599 hom., cov: 30)
Exomes 𝑓: 0.22 ( 38264 hom. )

Consequence

FRAS1
NM_025074.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.01

Publications

9 publications found
Variant links:
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
FRAS1 Gene-Disease associations (from GenCC):
  • Fraser syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Fraser syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 4-78421957-G-A is Benign according to our data. Variant chr4-78421957-G-A is described in ClinVar as Benign. ClinVar VariationId is 261807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRAS1NM_025074.7 linkc.4635G>A p.Pro1545Pro synonymous_variant Exon 34 of 74 ENST00000512123.4 NP_079350.5 Q86XX4-2
FRAS1NM_001166133.2 linkc.4635G>A p.Pro1545Pro synonymous_variant Exon 34 of 42 NP_001159605.1 Q86XX4-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRAS1ENST00000512123.4 linkc.4635G>A p.Pro1545Pro synonymous_variant Exon 34 of 74 5 NM_025074.7 ENSP00000422834.2 Q86XX4-2

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26307
AN:
151726
Hom.:
2599
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0959
Gnomad AMI
AF:
0.212
Gnomad AMR
AF:
0.176
Gnomad ASJ
AF:
0.129
Gnomad EAS
AF:
0.00155
Gnomad SAS
AF:
0.0819
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.238
Gnomad OTH
AF:
0.170
GnomAD2 exomes
AF:
0.177
AC:
43928
AN:
248534
AF XY:
0.175
show subpopulations
Gnomad AFR exome
AF:
0.0902
Gnomad AMR exome
AF:
0.166
Gnomad ASJ exome
AF:
0.138
Gnomad EAS exome
AF:
0.000445
Gnomad FIN exome
AF:
0.206
Gnomad NFE exome
AF:
0.240
Gnomad OTH exome
AF:
0.192
GnomAD4 exome
AF:
0.220
AC:
320878
AN:
1461024
Hom.:
38264
Cov.:
34
AF XY:
0.215
AC XY:
156608
AN XY:
726762
show subpopulations
African (AFR)
AF:
0.0874
AC:
2925
AN:
33470
American (AMR)
AF:
0.165
AC:
7366
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3486
AN:
26116
East Asian (EAS)
AF:
0.000504
AC:
20
AN:
39682
South Asian (SAS)
AF:
0.0917
AC:
7898
AN:
86164
European-Finnish (FIN)
AF:
0.212
AC:
11317
AN:
53372
Middle Eastern (MID)
AF:
0.113
AC:
648
AN:
5760
European-Non Finnish (NFE)
AF:
0.248
AC:
275690
AN:
1111406
Other (OTH)
AF:
0.191
AC:
11528
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
12559
25117
37676
50234
62793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9138
18276
27414
36552
45690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26314
AN:
151842
Hom.:
2599
Cov.:
30
AF XY:
0.169
AC XY:
12537
AN XY:
74184
show subpopulations
African (AFR)
AF:
0.0956
AC:
3961
AN:
41438
American (AMR)
AF:
0.176
AC:
2680
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
448
AN:
3470
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5146
South Asian (SAS)
AF:
0.0824
AC:
394
AN:
4782
European-Finnish (FIN)
AF:
0.199
AC:
2097
AN:
10530
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.238
AC:
16146
AN:
67922
Other (OTH)
AF:
0.169
AC:
355
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1047
2094
3140
4187
5234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.208
Hom.:
1850
Bravo
AF:
0.167
Asia WGS
AF:
0.0470
AC:
165
AN:
3478
EpiCase
AF:
0.220
EpiControl
AF:
0.225

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fraser syndrome 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.24
DANN
Benign
0.51
PhyloP100
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78575519; hg19: chr4-79343111; API